Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

Similar articles for PubMed (Select 7626389)

1.

Interferon alfa therapy in an infant with juvenile chronic myelogenous leukemia.

Toraldo R, Vetrano F, Pistoia V, Tolone C, Canino G, D'Avanzo M, Iafusco F.

Pediatr Hematol Oncol. 1995 Mar-Apr;12(2):189-94. Review.

PMID:
7626389
2.

Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.

Ohnishi K, Minami S, Ueda T, Nishimura M, Tsubaki K, Takemoto Y, Takeshita A, Sao H, Kageyama S, Ueda R, Ohno R.

Int J Hematol. 2000 Aug;72(2):229-36.

PMID:
11039674
3.

Congenital juvenile chronic myelogenous leukemia: therapeutic trial with interferon alpha-2.

Hazani A, Barak Y, Berant M, Bar-Maor A.

Med Pediatr Oncol. 1993;21(1):73-6.

PMID:
8426579
4.

Result of interferon-alpha therapy in patients with chronic myelogenous leukemia 60 years of age and older.

Cortes J, Kantarjian H, O'Brien S, Robertson LE, Pierce S, Talpaz M.

Am J Med. 1996 Apr;100(4):452-5.

PMID:
8610733
6.

Chemotherapy and bone marrow transplantation in the treatment of chronic myelogenous leukemia.

Kantarjian HM, Talpaz M.

Semin Oncol. 1994 Dec;21(6 Suppl 14):8-13. Review.

PMID:
7992099
7.

[Recent progress in therapy for chronic myelogenous leukemia].

Urabe A.

Gan To Kagaku Ryoho. 1997 Jul;24(9):1066-73. Review. Japanese.

PMID:
9239158
8.

Association between pretransplant interferon-alpha and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase.

Morton AJ, Gooley T, Hansen JA, Appelbaum FR, Bruemmer B, Bjerke JW, Clift R, Martin PJ, Petersdorf EW, Sanders JE, Storb R, Sullivan KM, Woolfrey A, Anasetti C.

Blood. 1998 Jul 15;92(2):394-401.

9.

[Successful treatment with donor leukocyte transfusion followed by interferon-alpha in a patient with relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation].

Maeda A, Yamamoto K, Kotone Y, Yamashita K, Yoshinaga N, Hirata H, Asagoe K, Nohgawa M, Takahashi A, Ohno H, Tashima M, Sasada M.

Rinsho Ketsueki. 1998 Jun;39(6):442-6. Japanese.

PMID:
9695673
12.

BCR/ABL mRNA and the P210(BCR/ABL) protein are downmodulated by interferon-alpha in chronic myeloid leukemia patients.

Pane F, Mostarda I, Selleri C, Salzano R, Raiola AM, Luciano L, Saglio G, Rotoli B, Salvatore F.

Blood. 1999 Oct 1;94(7):2200-7.

13.

Sequential homoharringtonine and interferon-alpha in the treatment of early chronic phase chronic myelogenous leukemia.

O'Brien S, Kantarjian H, Koller C, Feldman E, Beran M, Andreeff M, Giralt S, Cheson B, Keating M, Freireich E, Rios MB, Talpaz M.

Blood. 1999 Jun 15;93(12):4149-53.

14.

[Leukocyte transfusion as therapy of recurrent CML after allogenic bone marrow transplantation].

Wiesneth M, Hertenstein B, Bunjes D, Novotny J, Stefanic M, Heinze B, Schreiner T, Kubanek B, Heimpel H, Arnold R.

Beitr Infusionsther Transfusionsmed. 1994;32:276-80. German.

PMID:
9480108
15.

Use of alpha-2a-interferon to treat cytogenetic relapse of chronic myeloid leukemia after marrow transplantation.

Higano CS, Chielens D, Raskind W, Bryant E, Flowers ME, Radich J, Clift R, Appelbaum F.

Blood. 1997 Oct 1;90(7):2549-54.

16.

[Initial treatment of chronic myelogenous leukemia--interferon or bone marrow transplantation].

Urabe A.

Gan To Kagaku Ryoho. 1999 Sep;26(10):1381-6. Review. Japanese.

PMID:
10500523
17.

Effect of prior interferon alfa therapy on the outcome of allogeneic bone marrow transplantation for chronic myelogenous leukemia.

Giralt SA, Kantarjian HM, Talpaz M, Rios MB, Del Giglio A, Andersson BS, Przepiorka D, Deisseroth AB, Champlin RE.

J Clin Oncol. 1993 Jun;11(6):1055-61.

PMID:
8501491
18.

Chronic myelogenous leukemia: the news you have and haven't heard.

Kalaycio ME.

Cleve Clin J Med. 2001 Nov;68(11):913, 917, 920-1, 925-6. Review.

PMID:
11718431
19.

Treatment options for chronic myeloid leukemia: imatinib versus interferon versus allogeneic transplant.

Angstreich GR, Smith BD, Jones RJ.

Curr Opin Oncol. 2004 Mar;16(2):95-9. Review.

PMID:
15075898
20.

Donor leucocyte infusions for relapse in chronic myelogenous leukaemia.

Kumar L.

Lancet. 1994 Oct 22;344(8930):1101-2. No abstract available.

PMID:
7934489
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk